A rodent model of diabetic cardiomyopathy with diastolic dysfunction: haemodynamic and structural characteristics

被引：0
|
作者：
Connelly, K. A.
Kelly, D. K.
Zhang, Y. Z.
Prior, D. P.
Krum, H. K.
Gilbert, R. G.
机构：
[1] St Vincents Hosp, Dept Med & Cardiol, Fitzroy, Vic 3065, Australia
[2] Alfred Hosp, Dept Med, Prahran, Vic 3181, Australia
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：493 / 494
页数：2
相关论文
共 50 条
  • [31] The Nitroxyl Donor 1-Nitrosocyclohexyl Acetate Limits Cardiac Superoxide Upregulation and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
    Ritchie, Rebecca H.
    Cao, Nga
    Wong, Yung George
    Rosli, Sarah
    Kiriazis, Helen
    Huynh, Karina
    Qin, Chengxue
    Du, Xiao-Jun
    Kemp-Harper, Barbara K.
    CIRCULATION, 2014, 130
  • [32] MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
    Dai, Beibei
    Li, Huaping
    Fan, Jiahui
    Zhao, Yanru
    Yin, Zhongwei
    Nie, Xiang
    Wang, Dao Wen
    Chen, Chen
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [33] Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: Is It Really the First Marker of Diabetic Cardiomyopathy?
    Ernande, Laura
    Bergerot, Cyrille
    Rietzschel, Ernst R.
    De Buyzere, Marc L.
    Thibault, Helene
    PignonBlanc, Pierre Gautier
    Croisille, Pierre
    Ovize, Michel
    Groisne, Laure
    Moulin, Philippe
    Gillebert, Thierry C.
    Derumeaux, Genevieve
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2011, 24 (11) : 1268 - U147
  • [34] Aldose Reductase Inhibition by AT-001 Limits Diastolic Dysfunction and Adverse Remodelling in Diabetic Cardiomyopathy
    Karwi, Qutuba G.
    Gopal, Keshav
    Dakhili, Seyed Amirhossein Tabatabaei
    Wagg, Cory S.
    Zhang, Liyan
    Sun, Qiuyu
    Saed, Christina T.
    Panidarapu, Sai
    Perfetti, Riccardo
    Ramasamy, Ravichandran
    Ussher, John R.
    Lopaschuk, Gary
    DIABETES, 2022, 71
  • [35] MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
    Beibei Dai
    Huaping Li
    Jiahui Fan
    Yanru Zhao
    Zhongwei Yin
    Xiang Nie
    Dao Wen Wang
    Chen Chen
    Cardiovascular Diabetology, 17
  • [36] Electromechanical interplay in diabetic cardiomyopathy: relationship between diastolic dysfunction and T-wave alternans
    Zhen, Z.
    Wong, A.
    Zhao, C. T.
    Chen, Y.
    Siu, C. W.
    Tse, H. F.
    Yiu, K. H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 775 - 775
  • [37] Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy
    Wu, YM
    Tobias, AH
    Bell, K
    Barry, W
    Helmes, M
    Trombitas, K
    Tucker, R
    Campbell, KB
    Granzier, HL
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 111 - 119
  • [38] Interrogating Diastolic Dysfunction Using a Novel Stem Cell Model of Restrictive Cardiomyopathy
    Staudt, David W.
    Serrano, Ricardo
    Feyen, Dries
    Mercola, Mark
    CIRCULATION, 2021, 144
  • [39] Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy
    Cappetta, D. Donato
    Esposito, G.
    Piegari, E.
    Russo, R.
    Ciuffreda, L. P.
    Rivellino, A.
    Berrino, L.
    Rossi, F.
    De Angelis, A.
    Urbanek, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 136 - 136
  • [40] Interrogating Diastolic Dysfunction Using a Novel Stem Cell Model of Restrictive Cardiomyopathy
    Staudt, David
    Serrano, Ricardo
    Feyen, Dries
    Mercola, Mark
    PEDIATRICS, 2022, 149 (01)
12345